Sugar Derivatives TRIZ Cases

A [2+2+2] cyclotrimerization strategy synthesizes spiroannulated nucleosides using diyne intermediates and transition metal catalysts.

A supported gold catalyst converts uronic acids to aldaric acids under neutral conditions.

A polyethylene glycol spacer group separates fluorophores from guanine bases to increase fluorescence intensity.

Antibodies target heregulin-bound HER3 complexes to inhibit aggressive tumor cells while sparing normal tissue from toxicity.

An isolated oligonucleotide molecule forms a bimolecular quadruplex-duplex hybrid with target nucleic acids to modulate gene expression.

Modified cyclic dinucleotides activate the STING pathway to sustain robust immune responses against viral infections.

MicroRNAs drive somatic cell reprogramming to bypass c-Myc integration, eliminating tumorigenesis risks while maintaining high induction efficiency.

Characterized regulatory polynucleotides enable precise spatial and temporal gene expression control in transgenic plants.

Removing selection cassettes prevents transgene loss during ciliate conjugation.

Intercalating TINA monomers stabilize Hoogsteen triplexes at physiological pH, resolving instability in gene targeting.

Antisense RNA regulators interfere with RNAI repressive function to increase plasmid yield up to 5-fold while maintaining cell stability.

Dual simulated moving bed separators achieve high purity fructose extraction while minimizing oligosaccharide accumulation and water usage.

A functionalized nanoneedle array binds target nucleic acids within living cells to enable precise molecular profiling.

Halogenated and alcohol solvents resolve amorphous instability by producing high-purity, soluble 4′-epidaunorubicin hydrochloride crystals.

Early amine introduction eliminates late-stage amination and chiral resolution, boosting yield while avoiding toxic reagents.

Polymer-cyclodextrin-lipid conjugates encapsulate poorly water-soluble agents to reduce toxicity and dosage requirements.

A biocatalytic method prepares NMN using ribose, ATP, and segmented enzymes to avoid expensive PRPP substrates.

A recombinant DNA molecule encodes a modified E. coli phytase with targeted amino acid substitutions to boost secretion efficiency.

Modified exosomes transport miR-146b into target cells, resolving low cellular absorption rates in glioblastoma treatments.

Solid substrate probes target CpG dinucleotide motifs to replace subjective clinical observation with objective molecular diagnostic data.

Stabilized phosphate moieties at the 5' terminal enhance nuclease resistance and therapeutic efficacy while reducing toxicity risks.

Ion exchange chromatography with large pore sorbents purifies mRNA up to 10,000 nucleotides while avoiding high pressure and flammable solvents.

Pictet-Spengler modification of proteins with N-(2-aminoethyl)pyrrole derivatives preserves antigen-binding activity while ensuring long-term stability.

Deletion of terminator sequences in the rib leader eliminates feedback inhibition, increasing full-length mRNA stability and riboflavin yields.

Recombinant Brevibacillus bacteria secrete protein A directly, bypassing intracellular degradation and simplifying purification.

miR-330 compounds inhibit cancer cell proliferation by targeting MYC mRNA translation, addressing the lack of effective therapies for MYC-associated cancers.

PCR amplification and in vitro translation compare protein sizes to detect C-terminal truncation mutations, avoiding complex DNA sequencing.

Liver-targeted RNA overcomes systemic toxicity by enabling continuous local production of anti-fibrotic proteins like TRAIL and CEBPA.

A robotic bead collector extracts support beads from storage wells using vacuum pressure and linear motor positioning.

Vinyl-substituted heterocyclic reagents react specifically with polypeptide thiols to form stable thioether bonds, ensuring homogeneous product structures.

Segmented DNA intermediary complex facilitates parallel binding and branch migration, resolving complexity constraints in dynamic nucleic acid circuit design.

Randomized in-frame fusion polynucleotides introduce genetic diversity into host organisms through systematic sequence association.

Targeted siRNA inhibition of galectin-12 decreases sebaceous gland size without antibiotic resistance.

This integrated assay eliminates separate typing procedures to resolve the trade-off between comprehensive immune data acquisition and diagnostic time consumption.

Recombinant cellobiohydrolase variants exhibit enhanced thermostability and enzymatic activity through targeted amino acid substitutions.

Segmented Helix 73 RNA simplifies Erm mechanism studies and inhibitor screening by reducing substrate complexity.

Chlorinated substrates boost fluorescence intensity across broad pH ranges, resolving detection accuracy limits at varying spore levels.

Fluorinated imidazol-2-one nucleosides overcome toxicity and resistance trade-offs through lethal mutagenesis.

Inhibitory components block residual ribozyme activity during storage, extending shelf-life while enabling parallel ligand detection.

Modified nucleoside backslashes enhance oral bioavailability and reduce toxicity while selectively targeting viral replication.

Novel adenosine derivatives featuring an N-methylcarbamoyl group at position 5 of the sugar moiety and arylamino groups at position 6 of the purine moiety.

An iterative primer extension method isolates nucleic acid sequence variants through base-by-base polymerization.

Adhesive additives secure dried oligonucleotides in storage containers while non-reactive dyes provide visual confirmation of the composition presence.

Engineered Candida strains replace harsh chemical routes to produce hydroxy fatty acids with high selectivity and yield.

Furyl and thienyl substituted pyridyl chelating agents enhance luminescence yield and aqueous solubility for biomolecule labeling.